methanesulfonic acid 4-{2-[(dimethylcarbamoyl)methoxy]-2-oxoethyl}phenyl 4-carbamimidamidobenzoate
| Title | Journal |
|---|---|
| Reduced sodium transport with nasal administration of the prostasin inhibitor camostat in subjects with cystic fibrosis. | Chest 20130701 |
| Effect of a serine protease inhibitor on the progression of chronic renal failure. | American journal of physiology. Renal physiology 20121015 |
| In vivo contribution of serine proteases to the proteolytic activation of γENaC in aldosterone-infused rats. | American journal of physiology. Renal physiology 20121001 |
| An NF-κB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice. | The Journal of clinical investigation 20120402 |
| Proteolytic activation of the epithelial sodium channel and therapeutic application of a serine protease inhibitor for the treatment of salt-sensitive hypertension. | Clinical and experimental nephrology 20120201 |
| Duodenal myotomy blocks reduction of meal size and prolongation of intermeal interval by cholecystokinin. | Physiology & behavior 20120201 |
| Oral delivery system for two-pulse colonic release of protein drugs and protease inhibitor/absorption enhancer compounds. | Journal of pharmaceutical sciences 20110801 |
| The short term satiety peptide cholecystokinin reduces meal size and prolongs intermeal interval. | Peptides 20110601 |
| ONO 3403, a synthetic serine protease inhibitor, inhibits lipopolysaccharide-induced tumor necrosis factor-{alpha} and nitric oxide production and protects mice from lethal endotoxic shock. | Innate immunity 20110201 |
| Regulator of calcineurin 1 controls growth plasticity of adult pancreas. | Gastroenterology 20100801 |
| Refractory chronic urticaria treated effectively with the protease inhibitors, nafamostat mesilate and camostat mesilate. | Acta dermato-venereologica 20100701 |
| Efficacy of camostat mesilate against dyspepsia associated with non-alcoholic mild pancreatic disease. | Journal of gastroenterology 20100301 |
| Camostat attenuates airway epithelial sodium channel function in vivo through the inhibition of a channel-activating protease. | The Journal of pharmacology and experimental therapeutics 20090501 |
| Active site conformational changes of prostasin provide a new mechanism of protease regulation by divalent cations. | Protein science : a publication of the Protein Society 20090501 |
| Camostat mesilate inhibits prostasin activity and reduces blood pressure and renal injury in salt-sensitive hypertension. | Journal of hypertension 20090101 |
| Modelling of tumour--host coexistence In vitro in the presence of serine protease inhibitors. | In vivo (Athens, Greece) 20090101 |
| Activation of submucosal but not myenteric plexus of the gastrointestinal tract accompanies reduction of food intake by camostat. | Regulatory peptides 20081009 |
| CCK-induced pancreatic growth is not limited by mitogenic capacity in mice. | American journal of physiology. Gastrointestinal and liver physiology 20080501 |
| The proteinase inhibitor camostat mesilate suppresses pancreatic pain in rodents. | Life sciences 20070501 |
| Pancreatic diabetes in a follow-up survey of chronic pancreatitis in Japan. | Journal of gastroenterology 20070401 |
| Induction of early response genes in trypsin inhibitor-induced pancreatic growth. | American journal of physiology. Gastrointestinal and liver physiology 20070201 |
| The papilla of Vater just below the pylorus presenting as recurrent duodenal ulcer bleeding. | Internal medicine (Tokyo, Japan) 20070101 |
| [Effects of Chinese herbal medicines on spontaneous chronic pancreatitis in rats and the pathological relationships between formulas and syndromes]. | Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine 20060701 |
| Activation of the mTOR signalling pathway is required for pancreatic growth in protease-inhibitor-fed mice. | The Journal of physiology 20060615 |
| Properties of poly(lactic-co-glycolic acid) nanospheres containing protease inhibitors: camostat mesilate and nafamostat mesilate. | International journal of pharmaceutics 20060511 |
| Calcineurin-dependent and calcineurin-independent signal transduction pathways activated as part of pancreatic growth. | Pancreas 20060401 |
| Efficacy of camostat mesilate compared with famotidine for treatment of functional dyspepsia: is camostat mesilate effective? | Journal of gastroenterology and hepatology 20060401 |
| Camostat, an oral trypsin inhibitor, reduces pancreatic fibrosis induced by repeated administration of a superoxide dismutase inhibitor in rats. | Journal of gastroenterology and hepatology 20050601 |
| Water and enzyme secretion are tightly coupled in pancreatic secretion stimulated by food or CCK-58 but not by CCK-8. | American journal of physiology. Gastrointestinal and liver physiology 20050501 |
| Synthetic protease inhibitor camostat prevents and reverses dyslipidemia, insulin secretory defects, and histological abnormalities of the pancreas in genetically obese and diabetic rats. | Metabolism: clinical and experimental 20050501 |
| Preventive and therapeutic effects of the protease inhibitor camostat on pancreatic fibrosis and atrophy in CCK-1 receptor-deficient rats. | Pancreas 20050101 |
| Antimetastatic activity of a synthetic serine protease inhibitor, FOY-305 (Foypan). | In vivo (Athens, Greece) 20050101 |
| Tumor protein p53-induced nuclear protein 1 (TP53INP1) in spontaneous chronic pancreatitis in the WBN/Kob rat: drug effects on its expression in the pancreas. | JOP : Journal of the pancreas 20040701 |
| Calcineurin mediates pancreatic growth in protease inhibitor-treated mice. | American journal of physiology. Gastrointestinal and liver physiology 20040501 |
| [Autoimmune pancreatitis]. | Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20040110 |
| Circulating ethanol does not stimulate pancreatic secretion in conscious rats. | Pancreas 20031101 |
| CCK-58 is the only detectable endocrine form of cholecystokinin in rat. | American journal of physiology. Gastrointestinal and liver physiology 20030801 |
| Morphological relationship between intercalated duct and pancreatic islet in streptozotocin and/or camostat mesilate administrations in the chicken. | Anatomia, histologia, embryologia 20030401 |
| A possible defensive mechanism in the basal region of gastric mucosa and the healing of erosions. | Clinical hemorheology and microcirculation 20030101 |
| Different effects of oral administration of synthetic trypsin inhibitor on the pancreas between cholecystokinin-A receptor gene knockout mice and wild type mice. | Japanese journal of pharmacology 20020701 |
| Novel trial for the treatment of steroid dependency in minimal change disease: combined therapy of camostat mesilate and glycyrrhizin. | Nephron 20020301 |
| Protease inhibition in the intestinal lumen: attenuation of systemic inflammation and early indicators of multiple organ failure in shock. | Shock (Augusta, Ga.) 20020301 |
| [Thoracic aortic aneurysm with chronic disseminated intravascular coagulation treated successfully with orally administered camostat mesilate, warfarin and aspirin]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20020301 |
| Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-beta. | Gastroenterology 20010601 |
| Effects of synthetic serine protease inhibitors on proliferation and collagen synthesis of human pancreatic periacinar fibroblast-like cells. | Pancreas 20010401 |
| Preparation and characterization of biodegradable or enteric-coated microspheres containing the protease inhibitor camostat. | The Journal of pharmacy and pharmacology 20010201 |
| Acceleration of ulcer healing by cholecystokinin (CCK): role of CCK-A receptors, somatostatin, nitric oxide and sensory nerves. | Regulatory peptides 19990630 |
| New orally active serine protease inhibitors. | Journal of medicinal chemistry 19950707 |